PDS Biotechnology (PDSB) Non Operating Interest Expenses (2014 - 2026)
PDS Biotechnology (PDSB) reported Non Operating Interest Expenses of $3.38 million for Q2 2026, up 57.6% from $2.14 million a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Non Operating Interest Expenses (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, PDS Biotechnology's Non Operating Interest Expenses came in at $7.79 million, up 44.6% year-over-year; for FY2025, it was $5.34 million, up 14.2% from FY2024.
- Non Operating Interest Expenses has increased for three consecutive years, with a three-year compound annual growth rate of 59.5% (FY2022 to FY2025).
- By year, Non Operating Interest Expenses came in at $4.67 million in FY2024 (+11.1%), $4.21 million in FY2023 (+219.5%) and $1.32 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Non Operating Interest Expenses in data going back to Q3 2014.
- Year over year, Non Operating Interest Expenses gained in four of the last seven quarters, with growth averaging 17.2%.
- The high point for year-over-year Non Operating Interest Expenses in five years was Q3 2023 (growth of 169.0%); the low point was Q1 2025 (a decline of 20.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | PDS Biotechnology | 41.94 Mn | 41.94 Mn | - | 3.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 2.14 Mn |
| Mar 31, 2025 | 930,878.00 |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 995,397.00 |
| Mar 31, 2023 | 966,845.00 |
| Dec 31, 2022 | 919,193.00 |
| Sep 30, 2022 | 397,327.00 |
| Dec 31, 2019 | 32,953.00 |
| Mar 31, 2019 | 606.00 |
| Dec 31, 2018 | 890.00 |
| Sep 30, 2018 | 942.00 |
| Jun 30, 2018 | 804.00 |
API Access
PDS Biotechnology Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();